Literature DB >> 35449425

Autoimmune basal ganglia encephalitis with hemolytic anemia.

Ralph Werner1, Benedikt Lohr2, Peter Lodemann3, Jens Marcus Chemnitz4, Johannes C Woehrle5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35449425     DOI： 10.1007/s00277-022-04848-1

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   4.030


× No keyword cloud information.
  4 in total

1.  Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.

Authors:  Russell C Dale; Vera Merheb; Sekhar Pillai; Dongwei Wang; Laurence Cantrill; Tanya K Murphy; Hilla Ben-Pazi; Sophia Varadkar; Tim D Aumann; Malcolm K Horne; Andrew J Church; Thomas Fath; Fabienne Brilot
Journal:  Brain       Date:  2012-10-11       Impact factor: 13.501

2.  Autoantibody against erythrocyte protein 4.1 in a patient with autoimmune hemolytic anemia.

Authors:  H Wakui; H Imai; R Kobayashi; H Itoh; T Notoya; K Yoshida; Y Nakamoto; A B Miura
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

3.  D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N.

Authors:  Alicia V Binda; Nadine Kabbani; Ridwan Lin; Robert Levenson
Journal:  Mol Pharmacol       Date:  2002-09       Impact factor: 4.436

Review 4.  A clinical approach to diagnosis of autoimmune encephalitis.

Authors:  Francesc Graus; Maarten J Titulaer; Ramani Balu; Susanne Benseler; Christian G Bien; Tania Cellucci; Irene Cortese; Russell C Dale; Jeffrey M Gelfand; Michael Geschwind; Carol A Glaser; Jerome Honnorat; Romana Höftberger; Takahiro Iizuka; Sarosh R Irani; Eric Lancaster; Frank Leypoldt; Harald Prüss; Alexander Rae-Grant; Markus Reindl; Myrna R Rosenfeld; Kevin Rostásy; Albert Saiz; Arun Venkatesan; Angela Vincent; Klaus-Peter Wandinger; Patrick Waters; Josep Dalmau
Journal:  Lancet Neurol       Date:  2016-02-20       Impact factor: 44.182
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.